头颈游离皮瓣重建术后抗血栓策略:系统评价与网络Meta分析
该研究通过系统评价与臂基贝叶斯网络Meta分析,比较阿司匹林、右旋糖酐、低分子肝素、静脉或皮下普通肝素、前列腺素E1与无预防在头颈游离皮瓣重建术后的效果。结论支持个体化预防并需前瞻性研究指导指南。
要点
- 静脉普通肝素显著增加血肿风险(OR 4.18,95%CI 1.36-13.22)。
- 低分子肝素轻度升高再手术率(OR 2.25,95%CI 1.00-5.01)。
- 无抗血栓方案持续降低皮瓣丢失或血栓形成,支持个体化预防。
核心结论
- 抗血栓药物在减少皮瓣相关并发症方面获益有限,支持个体化预防并需前瞻性研究指导循证指南。
研究设计与样本
- 系统评价与臂基贝叶斯网络Meta分析,检索PubMed、Scopus和Google Scholar数据库。
主要发现
- 静脉普通肝素显著增加血肿风险(OR 4.18,95%CI 1.36-13.22)。
- 低分子肝素轻度升高再手术率(OR 2.25,95%CI 1.00-5.01)。
- 与无预防相比,无方案持续降低皮瓣丢失或血栓形成。
临床怎么用
- 头颈游离皮瓣重建术后抗血栓策略应个体化,权衡血肿与再手术风险。
- 静脉普通肝素与血肿风险显著增加相关,低分子肝素与再手术率轻度升高相关。
局限性
- 术后抗血栓治疗在微血管游离皮瓣重建中的作用仍存争议,无最佳方案共识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of postoperative antithrombotic therapy in microvascular free flap reconstruction remains controversial, with no consensus on the optimal regimen. METHODS: A systematic review and arm-based Bayesian network meta-analysis was conducted searching PubMed, Scopus, and Google Scholar databases. Aspirin (ASA), dextran, low-molecular-weight heparin (LMWH), intravenous or subcutaneous unfractionated heparin (IV UFH, SC UFH), prostaglandin E1 (PGE1) were compared with no prophylaxis. Primary outcomes were total and partial flap loss, vascular complications, hematoma, and reoperation. RESULTS: Fifty-four studies (17 773 patients) were included. IV UFH significantly increased hematoma risk (OR 4.18, 95% CI 1.36-13.22) and LMWH modestly raised reoperation rates (OR 2.25, 95% CI 1.00-5.01). No regimen consistently reduced flap loss or thrombosis compared with no prophylaxis. CONCLUSIONS: Antithrombotic agents showed limited benefit in reducing flap-related complications. These findings support individualized prophylaxis and highlight the need for prospective studies to inform evidence-based guidelines.
引用
- Uralov D, De Virgilio A, Canali L, et al. Postoperative Antithrombotic Strategies in Head and Neck Free Flap Reconstruction: A Systematic Review and Network Meta-Analysis. Head Neck. 2025. PMID: 41474089. doi:10.1002/hed.70158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。